Throughout her career Dr. Dugger has led numerous cross-disciplinary projects to enhance precision medicine approaches to dementias and Parkinson’s disease. This has resulted in a plethora of peer-reviewed manuscripts and book chapters, and fostered numerous private, state, and federally funded research endeavors. She obtained her PhD from Mayo Clinic and completed her postdoctoral fellowship and was promoted to a staff scientist in a research-based autopsy program at the Banner Sun Health Research Institute. She previously led the neuropathology core for academic and drug discovery groups within the Institute of Neurodegenerative Diseases at the University of California San Francisco. With over a decade of experience, she currently runs her own laboratory and is a co-leader for the neuropathology core of the University of California Davis Alzheimer’s Disease Center. She is both serious and enthusiastic about a future informed by clinicopathological research focusing on precision medicine approaches to dementias and Parkinson’s disease.
ML-based clinical decision support technology is becoming more popular among healthcare provider organizations due to its ability to analyze large volumes of information, ensure that key data don’t escape the attention of the care team, and reduce alert fatigue. Unfortunately, most health systems are unprepared for how to select and deploy these new solutions. This session will discuss steps that hospitals and health systems should take to avoid mistakes and pitfalls.